BRAF NP_004324.2:P.V600E

Clinical trials for BRAF NP_004324.2:P.V600E explained in plain language.

Never miss a new study

Get alerted when new BRAF NP_004324.2:P.V600E trials appear

Sign up with your email to follow new studies for BRAF NP_004324.2:P.V600E, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New triple attack on tough colon cancer shows promise

Disease control Ongoing

This study is testing a combination of three drugs (encorafenib, cetuximab, and nivolumab) for people with advanced colorectal cancer that has a specific BRAF gene mutation and has spread or cannot be removed by surgery. The goal is to find the safest dose and see if the three dr…

Matched conditions: BRAF NP_004324.2:P.V600E

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 16, 2026 15:24 UTC

BRAF NP_004324.2:P.V600E

Get alerted when new BRAF NP_004324.2:P.V600E trials appear

New triple attack on tough colon cancer shows promise